Table 1 Cohort characteristics and sleep macro‑architecture. Values are mean ± SD; Female, % is the proportion of women in each group.

From: Mapping nocturnal arousal across sleep and pain disorders

Metric

Control

iRBD

NT1

NREM parasomnia

Fibromyalgia

n

40

19

19

18

13

Female, %

50.0

10.5

52.6

55.6

92.3

Age (years)

46.2 ± 16.4

60.5 ± 9.7

29.9 ± 10.9

39.6 ± 6.9

44.5 ± 6.1

TST (mins)

420.7 ± 35.6

364.2 ± 55.7

413.4 ± 45.3

385.4 ± 42.8

348.6 ± 84.6

SE (%)

84.4 ± 8.2

76.4 ± 11.9

86.1 ± 5.7

86.1 ± 8.0

72.9 ± 15.6

WASO (mins)

59.3 ± 39.1

91.4 ± 47.6

60.1 ± 27.2

54.4 ± 41.7

101.7 ± 63.7

Arousal Index (ev/hr)

11.6 ± 4.0

20.5 ± 8.0

16.8 ± 5.1

15.4 ± 6.4

20.7 ± 9.8

AHI (Ev/Hr)

1.9 ± 0.7

3.5 ± 3.0

1.4 ± 1.3

1.2 ± 1.8

1.4 ± 1.6

N1% of TST

8.8 ± 4.1

12.0 ± 5.5

10.2 ± 5.7

8.7 ± 2.8

14.0 ± 12.5

N2% of TST

47.2 ± 7.0

42.4 ± 8.8

43.1 ± 7.1

48.1 ± 8.4

40.0 ± 7.9

N3% of TST

21.2 ± 6.0

24.8 ± 6.7

26.1 ± 6.6

21.6 ± 8.2

24.9 ± 7.5

REM % of TST

22.7 ± 5.0

20.8 ± 6.4

20.6 ± 5.2

21.6 ± 4.6

21.0 ± 6.8

  1. TST, total sleep time; SE, sleep efficiency; WASO, wake after sleep onset; AHI, apnoea–hypopnoea index. Controls were drawn from MASS; patient cohorts were recruited at a tertiary sleep centre. See Supplementary Methods for inclusion/exclusion criteria and scoring rules.